Background: Blood lactate concentration is a marker of tissue perfusion and helps guide therapeutic interventions in critically ill horses. In both humans and dogs, administration of corticosteroids can increase blood lactate concentration, leading to type B hyperlactatemia. This effect could be a consequence of the impact of corticosteroids on glucose metabolism.
T he monitoring of blood lactate concentrations has become an established component of critical care in equine practice, especially with the validation of pointof-care devices for horses. [1] [2] [3] [4] [5] Blood lactate measurements now are frequently used to assess tissue perfusion, guide initial fluid resuscitation, and help formulate prognoses in horses. 6 Several studies have shown that blood lactate concentration is associated with outcome in adult horses and foals. [7] [8] [9] [10] [11] [12] [13] [14] [15] Dexamethasone is a corticosteroid often used in equine practice to treat a variety of diseases such as recurrent airway obstruction, inflammatory airway disease, or hemolytic anemia, with suggested dosages ranging from 0.05 to 0.1 mg/kg q24h. 16 A previous study in dogs showed that administration of prednisone caused a statistically significant increase in lactate concentrations, 17 a phenomenon also reported in humans. 18 The mechanism behind this effect is not fully understood, but may be related to the effect of corticosteroids on carbohydrate metabolism, 19 whereby increased rates of glucose production and utilization 20 lead to increased production of pyruvate and lactate. 21 Given that blood lactate concentrations often are monitored in sick horses and given the common use of corticosteroids in the treatment of various diseases, it is important to know whether the administration of dexamethasone has an impact on blood lactate concentration in horses. The treatments of type A and type B hyperlactatemia 6, 22, 23 differ, and overly aggressive fluid therapy to correct lactate concentrations in cases of unrecognized type B hyperlactatemia is unlikely to be successful and could be dangerous. Additionally, failure to recognize type B hyperlactatemia could lead to perceived treatment failure or attribution of a worse prognosis than is warranted.
To our knowledge, the effect of glucocorticoid administration on blood lactate concentrations has not been examined in horses. The objective of our study therefore was to examine the impact of a low dose of dexamethasone on resting blood lactate concentrations in healthy horses. Given the possible link between glucose metabolism and hyperlactatemia, we also concurrently measured blood glucose concentrations. We hypothesized that the administration of dexamethasone would result in a statistically significant increase in blood lactate concentrations compared to the injection of saline and that the changes in blood lactate concentration would be associated with changes in blood glucose concentration.
Materials and Methods

Experimental Design
We used a randomized controlled blinded cross-over design. The horses were randomly assigned a number and then randomly distributed into the dexamethasone treatment or saline control group, with 5 horses in each. The investigators were blinded to the treatment that each horse received (dexamethasone or saline).
Animals
Ten adult horses (3 geldings and 7 mares) ranging from 8 to 22 years of age were used. The horses were members of the teaching herd of our institution and were deemed healthy based on physical examination, history, and behavior. The horses were housed in pens as pairs according to temperament to decrease the stress associated with mixing. Horses were fed mixed grass hay twice daily and had ad libitum access to water. By the time of blood sampling, the horses had received their morning feeding. Three days were allotted for acclimation before any handling, injections, or blood collection. A physical examination was performed on each horse daily. Body condition scores for all horses were 5 or 6 on a 9-point scale. All procedures were approved by the Animal Care Committee of our institution. The study started with 10 horses, but 1 mare was removed after 3 days because of her resistance to blood collection. All of her data were removed from further analysis, leaving a total of 9 horses for the study.
Each horse received a 0.05 mg/kg dose of dexamethasone a or equivalent volume of saline into the musculature of the neck between 8:30 AM and 12:30 PM for 7 days. The horses were injected in the same order (except for 2 injection times for 2 horses) and with a similar time of injection on each day (within 1 hour and 30 minutes for all horses, except for 2 horses in which there was a difference of 2 hours and 30 minute between the earlier and later injection times). The time between injection and blood sampling was targeted at 2 hours for each horse. The injection site was alternated between the left and right side of the neck each day. Blood was collected 24 hours before the start of injections (day 0), 2 hours after each IM injection of dexamethasone or saline (days 1-7), and 24 hours after the last treatment (day 8). Care was taken to avoid stressing the horses during blood collection. Blood was collected into sodium heparin Vacutainer tubes.
b Groups were reversed, and the protocol was repeated after a 7-week washout period.
Blood Processing
Lactate measurements on whole blood samples were performed within 5 minutes of blood collection using the Lactate Pro blood lactate test meter c and test strips. c This device has been validated for measuring blood lactate concentration in horses. 2, 4 Lactate concentrations <0.8 mmol/L read as "low" and were assigned a value of 0.7 mmol/L for statistical analysis. Blood glucose concentration was measured on whole blood within 5 minutes of blood collection using a handheld blood glucose monitoring system d that has been validated in horses. 24 All lactate and glucose concentrations were determined in duplicate and averaged for statistical analysis.
Data Analysis
The individual daily blood lactate and blood glucose concentrations are shown for each horse as scatter plots, with the mean and 95% confidence interval (95% CI; Figs 1 and 2). The mean blood lactate and blood glucose concentrations on days 0-8 were compared between the treatment groups using a 2-way repeatedmeasure ANOVA with Sidak's multiple comparisons test. The mean difference for each comparison is shown graphically with 95% CI and associated P value. Linear mixed-effects models were used to examine the effects of treatment and time (as fixed effects) on lactate and glucose concentrations (as outcomes), adjusting for the baseline glucose concentration at day 0 in the case of glucose, after accounting for the nested data structure from horses and phases of the cross-over experiment (as random effects). In addition, a similar model was used to study the relationship between lactate and glucose concentrations, adjusting for treatment and time. The assumptions of normality and equal variance were assessed for using the models. The 2-way repeated-measure ANOVA and all the of graphs were performed using Prism version 6.
e The linear mixed-effects model analyses were performed using R version 3.3.0 and the "nlme" package version 3.1. A P value of <.05 was considered to indicate statistical significance.
Results
Blood Lactate
The average time from injection (dexamethasone or saline) to blood collection was 2 hours and 2 minutes with a range of 1 hour 58 minutes to 2 hours and 14 minutes. Blood lactate concentrations at baseline (day 0) were below the detection limit of the lactate reader (<0.8 mmol/L) for all horses (Fig 1A) . The daily administration of dexamethasone led to a statistically significant increase in blood lactate concentrations compared to the administration of saline, starting on day 2 and persisting until day 7, before returning to baseline values on day 8, 24 hours after the last dose of dexamethasone ( Fig 1A) . The daily mean lactate differences between the treated and control group, 95% CI, and associated P values are shown in Figure 1B . Mixed linear model analysis showed that dexamethasone treatment (but not time) had a statistically significant effect on lactate concentration (P = .006). The least squares mean lactate concentration over time (day 1 to day 8) was 0.93 mmol/L (95% CI: 0.87-0.99) in the dexamethasone-treated group compared to 0.71 mmol/L (95% CI: 0.70-0.73) for the saline group.
Blood Glucose
Similar to the changes observed for resting blood lactate concentrations, the daily administration of dexamethasone led to a statistically significant increase in blood glucose concentrations compared to the administration of saline, starting on day 2 and persisting until the end of the study on day 8, 24 hours after the last injection of dexamethasone (Fig 2A) . The mean glucose concentration difference between the treated and control group, 95% CI, and associated P value are shown in Figure 2B . Both treatment and time, as well as their interaction, had statistically significant effects on blood glucose concentration, with P values of .033, .003, and .011, respectively. The baseline (day 0) glucose concentration of each horse did not have an effect on subsequent glucose measurements. The least squares mean glucose concentration over time (day 1 to day 8) was 8.01 mmol/L (95% CI: 7.12-8.89) in the dexamethasone-treated group compared to 5.62 mmol/L (95% CI: 4.80-6.44) in saline group.
Lactate-Glucose Correlation
Throughout the study, blood lactate concentrations appeared to vary according to changes in blood glucose concentrations (Fig 3) . Mixed linear model analysis showed that there was a positive relationship between lactate and glucose concentrations, with a 0.07 mmol/L (95% CI: 0.05-0.09) increase in lactate concentration per unit increase in glucose concentration (P < .0001).
Discussion
We demonstrated that administration of a low dose of dexamethasone to healthy horses induced a statistically significant increase in resting blood lactate concentrations. These results may be important given the widespread monitoring of blood lactate concentrations in critically ill horses and the common use of dexamethasone in the treatment of various diseases of horses.
Despite the potential important clinical implications of glucocorticosteroid-induced type B hyperlactatemia, only a few studies have documented this phenomenon. In healthy dogs, daily administration of a low (1 mg/kg) or high (4 mg/kg) dosage of prednisone led to a statistically significant increase in blood lactate concentrations up to 4.3 mmol/L for the high prednisone dosage, well above what would be considered normal. 17 These results were similar to an earlier study, also showing an increase in blood lactate concentrations in healthy dogs after administration of methylprednisolone. 20 This phenomenon also is observed in human medicine, where cardiac surgery patients receiving a single perioperative high dose of dexamethasone had increased blood lactate (2.1 mmol/L versus 0.7 mmol/L) and blood glucose concentrations (10.0 mmol/L versus 8.0 mmol/L) after surgery compared to the placebo group. 18 Similarly, an increase in blood lactate concentrations also was observed in humans with Cushing's disease or after corticosteroid administration. 21 The mechanism by which corticosteroids induce hyperlactatemia is not fully understood. Given the diverse effects of corticosteroids 19, 25 and the complexity of lactate metabolism, 26 several factors probably contribute to corticosteroid-induced hyperlactatemia. 18 One potential explanation for dexamethasone-induced type B hyperlactatemia is the hyperglycemic effect of glucocorticosteroids. Glucocorticoids are stress hormones that are essential to mammalian glucose homeostasis. 25 By stimulating hepatic gluconeogenesis and inhibiting glucose uptake and utilization in muscle and adipose tissue, they allow plasma glucose concentrations to increase, an adaptation that might be important in maintaining optimal brain function in times of stress. 25 Blood glucose and lactate concentrations appear to be closely related, and an increase in blood glucose concentrations in human cardiac surgery patients appears to precede an increase in blood lactate concentrations. 18 In patients with septic or hemorrhagic shock, hyperlactatemia may occur secondary to marked increases in glucose turnover. 27 Finally, increased gluconeogenesis arising from increased protein metabolism after glucocorticoid administration, and subsequently increased glucose utilization, might also contribute to increased blood lactate concentrations in healthy dogs receiving methylprednisolone.
20 Although a causal relationship cannot be ascertained from our study, a statistically significant positive relationship between blood glucose and lactate concentrations was identified in healthy horses receiving dexamethasone.
Whereas dexamethasone administration was associated with a statistically significant increase in blood lactate concentration in our study, the increase (up to 1.6 mmol/L) was not considered to be clinically relevant. However, administration of higher doses of dexamethasone in horses with steroid-responsive conditions potentially associated with type A hyperlactatemia (eg, purpura hemorrhagica or immune-mediated hemolytic anemia) or in horses with decreased lactate clearance could confound interpretation of blood lactate concentrations, particularly if lactate concentrations were to exceed the upper reference value in horses.
The time frame of the effect of dexamethasone on blood lactate concentration in horses is not known. The 2-hour postinjection time chosen in our study was based on the known effects of steroid administration on glucose metabolism in horses. 28 The effect of a single low dose of dexamethasone (similar to the dose used in our study) on glucose homeostasis in healthy horses can be detected as early as 2 hours postdexamethasone injection 28 with maximal effect at 24 hours postinjection. Furthermore, although the IM route of steroid administration was chosen in our study, we hypothesize that similar results would have been observed if the IV route of steroid administration had been used given that the pharmacokinetics of dexamethasone have been shown to be similar for IV and IM injections. 29 Our study has a few limitations. First, the method of lactate measurement used had a lower limit of detection of 0.8 mmol/L. In healthy horses, blood lactate concentrations often are well below 0.8 mmol/L, and therefore, we had several samples that read as "low" on our handheld device. Although we attributed a value of 0.7 mmol/L to these readings, it is quite likely that several of these were lower than 0.7 mmol/L. Therefore, we might have underestimated the difference between the treatment and control groups. Although not affecting the conclusions of our study, the use of more sensitive techniques for measuring blood lactate concentration might identify an even more pronounced effect of dexamethasone on resting blood lactate concentrations in horses. Second, our study used a relatively low dosage of dexamethasone (0.05 mg/kg) despite the fact that many horses with corticosteroid-responsive illnesses often receive, at least initially, a higher dosage of dexamethasone (0.1 mg/kg). Using a higher dosage of dexamethasone in our study might have identified higher increases in blood lactate concentrations that could have been more clinically relevant. Third, daily lactate concentrations can vary slightly throughout the day, and this variation could have affected the results of our study. The inclusion of a control group and our efforts to inject the horses and collect blood at approximately the same time each day should have minimized this potential confounding factor. Fourth, although the handheld meter used in this study has been validated in horses, the use of whole blood samples to measure lactate concentrations can lead to clinically relevant inaccuracies with some lactate meters. 5 These inaccuracies were noted to be greatest when the lactate concentration is >5 mmol/L. Given that all of the lactate concentrations in our study were <5 mmol/L, and given that the meter we used is more accurate (in cats 30 and dogs 31 ) than the lactate meter used in the abovementioned study, 5 it is unlikely that our results would change if a different methodology was used to measure blood lactate concentration. Finally, we did not continue our blood glucose measurements beyond day 8, even though the blood glucose concentrations were still increased in the dexamethasone-treated group, and future studies should document the time required for the blood glucose concentration to return to control concentrations.
In conclusion, we demonstrated that IM injection of a low dose of dexamethasone increases resting blood lactate concentrations in horses, similar to what has been documented in humans and dogs. The pathophysiology of the increase in blood lactate concentration likely is multifactorial, although glucocorticoid-induced hyperglycemia likely plays a role. Clinicians monitoring blood lactate concentrations should take these findings into account when making decisions regarding diagnosis, care, and prognosis of horses receiving dexamethasone.
